552 related articles for article (PubMed ID: 26435214)
1. Silent information regulator 1 (SIRT1) ameliorates liver fibrosis via promoting activated stellate cell apoptosis and reversion.
Wu Y; Liu X; Zhou Q; Huang C; Meng X; Xu F; Li J
Toxicol Appl Pharmacol; 2015 Dec; 289(2):163-76. PubMed ID: 26435214
[TBL] [Abstract][Full Text] [Related]
2. SOD3 deficiency induces liver fibrosis by promoting hepatic stellate cell activation and epithelial-mesenchymal transition.
Sun YL; Bai T; Zhou L; Zhu RT; Wang WJ; Liang RP; Li J; Zhang CX; Gou JJ
J Cell Physiol; 2021 Jun; 236(6):4313-4329. PubMed ID: 33230845
[TBL] [Abstract][Full Text] [Related]
3. Ferulic acid attenuates liver fibrosis and hepatic stellate cell activation via inhibition of TGF-β/Smad signaling pathway.
Mu M; Zuo S; Wu RM; Deng KS; Lu S; Zhu JJ; Zou GL; Yang J; Cheng ML; Zhao XK
Drug Des Devel Ther; 2018; 12():4107-4115. PubMed ID: 30584275
[TBL] [Abstract][Full Text] [Related]
4. DNMT1 controls LncRNA H19/ERK signal pathway in hepatic stellate cell activation and fibrosis.
Yang JJ; She Q; Yang Y; Tao H; Li J
Toxicol Lett; 2018 Oct; 295():325-334. PubMed ID: 30010033
[TBL] [Abstract][Full Text] [Related]
5. Glycyrrhizic acid inhibits apoptosis and fibrosis in carbon-tetrachloride-induced rat liver injury.
Liang B; Guo XL; Jin J; Ma YC; Feng ZQ
World J Gastroenterol; 2015 May; 21(17):5271-80. PubMed ID: 25954100
[TBL] [Abstract][Full Text] [Related]
6. Exosomal MALAT1 derived from hepatic cells is involved in the activation of hepatic stellate cells via miRNA-26b in fibrosis induced by arsenite.
Dai X; Chen C; Xue J; Xiao T; Mostofa G; Wang D; Chen X; Xu H; Sun Q; Li J; Wei Y; Chen F; Quamruzzaman Q; Zhang A; Liu Q
Toxicol Lett; 2019 Nov; 316():73-84. PubMed ID: 31513886
[TBL] [Abstract][Full Text] [Related]
7. Smad2 increases the apoptosis of activated human hepatic stellate cells induced by TRAIL.
Xu F; Zhou D; Meng X; Wang X; Liu C; Huang C; Li J; Zhang L
Int Immunopharmacol; 2016 Mar; 32():76-86. PubMed ID: 26802603
[TBL] [Abstract][Full Text] [Related]
8. K⁺-channel inhibition reduces portal perfusion pressure in fibrotic rats and fibrosis associated characteristics of hepatic stellate cells.
Freise C; Heldwein S; Erben U; Hoyer J; Köhler R; Jöhrens K; Patsenker E; Ruehl M; Seehofer D; Stickel F; Somasundaram R
Liver Int; 2015 Apr; 35(4):1244-52. PubMed ID: 25212242
[TBL] [Abstract][Full Text] [Related]
9. Synergistic anti-liver fibrosis actions of total astragalus saponins and glycyrrhizic acid via TGF-β1/Smads signaling pathway modulation.
Zhou Y; Tong X; Ren S; Wang X; Chen J; Mu Y; Sun M; Chen G; Zhang H; Liu P
J Ethnopharmacol; 2016 Aug; 190():83-90. PubMed ID: 27282665
[TBL] [Abstract][Full Text] [Related]
10. Newcastle disease virus represses the activation of human hepatic stellate cells and reverses the development of hepatic fibrosis in mice.
Li YL; Wu J; Wei D; Zhang DW; Feng H; Chen ZN; Bian H
Liver Int; 2009 Apr; 29(4):593-602. PubMed ID: 19192169
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor binding protein related protein 1 knockdown attenuates hepatic fibrosis via the regulation of MMPs/TIMPs in mice.
Ren JJ; Huang TJ; Zhang QQ; Zhang HY; Guo XH; Fan HQ; Li RK; Liu LX
Hepatobiliary Pancreat Dis Int; 2019 Feb; 18(1):38-47. PubMed ID: 30243878
[TBL] [Abstract][Full Text] [Related]
12. Propranolol prevents liver cirrhosis by inhibiting hepatic stellate cell activation mediated by the PDGFR/Akt pathway.
Ding Q; Li Z; Liu B; Ling L; Tian X; Zhang C
Hum Pathol; 2018 Jun; 76():37-46. PubMed ID: 29514109
[TBL] [Abstract][Full Text] [Related]
13. Role of growth factor receptor-bound 2 in CCl
Ge S; Xiong Y; Wu X; Xie J; Liu F; He J; Xiang T; Cheng N; Lai L; Zhong Y
Biomed Pharmacother; 2017 Aug; 92():942-951. PubMed ID: 28618656
[TBL] [Abstract][Full Text] [Related]
14. Flavonoid-rich Scabiosa comosa inflorescence extract attenuates CCl
Ma Y; Yuan H; Jin R; Bao X; Wang H; Su X; Mu MGSL; Liang J; Zhang J; Wu X
Biomed Pharmacother; 2018 Oct; 106():426-433. PubMed ID: 29990830
[TBL] [Abstract][Full Text] [Related]
15. Icaritin induces cell death in activated hepatic stellate cells through mitochondrial activated apoptosis and ameliorates the development of liver fibrosis in rats.
Li J; Liu P; Zhang R; Cao L; Qian H; Liao J; Xu W; Wu M; Yin Z
J Ethnopharmacol; 2011 Sep; 137(1):714-23. PubMed ID: 21726622
[TBL] [Abstract][Full Text] [Related]
16. SIRT1 antagonizes liver fibrosis by blocking hepatic stellate cell activation in mice.
Li M; Hong W; Hao C; Li L; Wu D; Shen A; Lu J; Zheng Y; Li P; Xu Y
FASEB J; 2018 Jan; 32(1):500-511. PubMed ID: 28970250
[TBL] [Abstract][Full Text] [Related]
17. Rosiglitazone Inhibits Activation of Hepatic Stellate Cells via Up-Regulating Micro-RNA-124-3p to Alleviate Hepatic Fibrosis.
Zhi SC; Chen SZ; Li YY; Li JJ; Zheng YH; Yu FX
Dig Dis Sci; 2019 Jun; 64(6):1560-1570. PubMed ID: 30673982
[TBL] [Abstract][Full Text] [Related]
18. Differential TM4SF5-mediated SIRT1 modulation and metabolic signaling in nonalcoholic steatohepatitis progression.
Ryu J; Kim E; Kang MK; Song DG; Shin EA; Lee H; Jung JW; Nam SH; Kim JE; Kim HJ; Son T; Kim S; Kim HY; Lee JW
J Pathol; 2021 Jan; 253(1):55-67. PubMed ID: 32918742
[TBL] [Abstract][Full Text] [Related]
19. Effect of NLRC5 on activation and reversion of hepatic stellate cells by regulating the nuclear factor-κB signaling pathway.
Zhang YZ; Yao JN; Zhang LF; Wang CF; Zhang XX; Gao B
World J Gastroenterol; 2019 Jun; 25(24):3044-3055. PubMed ID: 31293340
[TBL] [Abstract][Full Text] [Related]
20. A histone deacetylase inhibitor, largazole, decreases liver fibrosis and angiogenesis by inhibiting transforming growth factor-β and vascular endothelial growth factor signalling.
Liu Y; Wang Z; Wang J; Lam W; Kwong S; Li F; Friedman SL; Zhou S; Ren Q; Xu Z; Wang X; Ji L; Tang S; Zhang H; Lui EL; Ye T
Liver Int; 2013 Apr; 33(4):504-15. PubMed ID: 23279742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
